(Q39477283)

12 September 2017

title

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes (English)

1 reference

12 September 2017

0 references

Alessia Parodi

1

1 reference

12 September 2017

Florinda Battaglia

2

1 reference

12 September 2017

Francesca Kalli

3

1 reference

12 September 2017

Francesca Ferrera

4

1 reference

12 September 2017

Giuseppina Conteduca

5

1 reference

12 September 2017

Samuele Tardito

6

1 reference

12 September 2017

Silvia Stringara

7

1 reference

12 September 2017

Federico Ivaldi

8

1 reference

12 September 2017

Simone Negrini

9

1 reference

12 September 2017

Giacomo Borgonovo

10

1 reference

12 September 2017

Alchiede Simonato

11

1 reference

12 September 2017

Paolo Traverso

12

1 reference

12 September 2017

Giorgio Carmignani

13

1 reference

12 September 2017

Daniela Fenoglio

14

1 reference

12 September 2017

Gilberto Filaci

15

1 reference

12 September 2017

language of work or name

1 reference

29 January 2013

1 reference

Cancer Immunology, Immunotherapy

12 September 2017

published in

1 reference

12 September 2017

volume

62

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

851-862

1 reference

CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Regulatory T cells: key controllers of immunologic self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Regulatory T cells in gastrointestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

21 January 2018

The dual role of IL-10.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

Regulation of interferon-gamma during innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1392-Z

10.1007/S00262-013-1392-Z

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference